Clairvest Invests in Beneficial Reuse Management
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) ('CVG') today announced that it, together with Clairvest Equity Partners VII ('CEP VII', collectively 'Clairvest'), has recapitalized and invested in Beneficial Reuse Management ('BRM' or the 'Company') from Skyline Global Partners and other shareholders. Clairvest has been actively investing in the environmental services sector for over 19 years, and this transaction represents our 10th partnership in the industry.
BRM distributes products to the agriculture, landscape, wallboard, and construction end-markets by reusing or converting certain industrial waste streams into value-add products. BRM was founded in 1999 by Dave Schuurman and is currently led by Trevor Schuurman as its CEO & President. Headquartered in Chicago, Illinois, BRM operates six processing and manufacturing facilities and maintains a distribution network of over 116 locations to store and distribute materials for beneficial reuse programs.
'BRM is a unique company delivering a compelling value proposition for its customer base, including: (i) meeting the growing demand for specialty agricultural nutrients and recycled wallboard, and (ii) providing innovative waste disposal and recycling solutions for industrial waste generators. We are excited to partner with and support Trevor and his management team to execute an aggressive growth plan and become a leading beneficial reuse and industrial recycling company in the U.S.,' said Michael Castellarin, Managing Director of Clairvest.
'Finding innovative and environmentally friendly waste disposal alternatives for our customers has been a key focus for our business over the past two decades. We remain dedicated to partnering with our customers to provide innovative and effective beneficial reuse solutions – all while contributing to a healthier planet. With Clairvest's deep industry expertise and strong track record supporting the growth of its partners, we are gaining more than just a capital partner – we are gaining a strategic ally to support our continued growth,' said Trevor Schuurman, CEO & President of BRM.
Raymond James served as exclusive financial advisor to BRM.
The BRM investment is Clairvest's 69th platform investment and the third investment of CEP VII, a US$1.2 billion investment pool, US$300 million of which is from CVG.
About ClairvestClairvest's mission is to partner with entrepreneurs to help them build strategically significant businesses. Founded in 1987 by a group of successful Canadian entrepreneurs, Clairvest is a top performing private equity management firm with CAD $4.6 billion of capital under management. Clairvest invests its own capital and that of third parties through the Clairvest Equity Partners limited partnerships in owner-led businesses. Under the current management team, Clairvest has initiated investments in 69 different platform companies and generated top quartile performance over an extended period.
Contact InformationStephanie LoDirector of Investor Relations and MarketingClairvest Group Inc.Tel: (416) 925-9270stephaniel@clairvest.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
June 2025's Spotlight On Promising Penny Stocks
As the U.S. stock market experiences a rally fueled by optimism over U.S.-China trade talks and robust corporate earnings, investors are increasingly exploring diverse investment opportunities. Penny stocks, a term that may seem outdated yet remains relevant, represent shares of smaller or newer companies that can offer significant growth potential when backed by strong financial health. In this article, we will explore several penny stocks that demonstrate balance sheet strength and long-term potential, providing investors with opportunities to uncover hidden value in the market. Name Share Price Market Cap Financial Health Rating Imperial Petroleum (IMPP) $3.02 $103.93M ★★★★★★ New Horizon Aircraft (HOVR) $0.935 $29.35M ★★★★★★ Waterdrop (WDH) $1.475 $533.45M ★★★★★★ Greenland Technologies Holding (GTEC) $2.06 $35.83M ★★★★★★ WM Technology (MAPS) $1.11 $186.68M ★★★★★★ Perfect (PERF) $1.815 $184.86M ★★★★★★ Table Trac (TBTC) $4.86 $22.55M ★★★★★★ Flexible Solutions International (FSI) $4.32 $54.64M ★★★★★★ BAB (BABB) $0.8311 $6.04M ★★★★★★ Lifetime Brands (LCUT) $3.43 $76.88M ★★★★★☆ Click here to see the full list of 709 stocks from our US Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Aldeyra Therapeutics, Inc. is a biotechnology company focused on discovering and developing therapies for immune-mediated and metabolic diseases, with a market cap of approximately $159.32 million. Operations: Aldeyra Therapeutics, Inc. does not report any revenue segments. Market Cap: $159.32M Aldeyra Therapeutics, with a market cap of US$159.32 million, is a pre-revenue biotechnology firm navigating the challenging landscape of clinical trials and regulatory approvals. Despite recent setbacks from the FDA regarding its dry eye treatment candidate reproxalap, the company achieved significant milestones in Phase 3 trials that may address previous concerns. Financially, Aldeyra maintains strong short-term liquidity with US$92.7 million in assets against liabilities and has more cash than debt, providing a runway exceeding one year. However, high volatility and ongoing losses highlight inherent risks typical for companies at this developmental stage in the biotech sector. Unlock comprehensive insights into our analysis of Aldeyra Therapeutics stock in this financial health report. Explore Aldeyra Therapeutics' analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Maravai LifeSciences Holdings, Inc. is a life sciences company that offers products supporting the development of drug therapies, vaccines, cell and gene therapies, and diagnostics across various global regions with a market cap of $608.64 million. Operations: The company generates revenue primarily from Nucleic Acid Production, which accounts for $179.08 million, and Biologics Safety Testing, contributing $62.78 million. Market Cap: $608.64M Maravai LifeSciences Holdings, with a market cap of US$608.64 million, faces challenges typical for penny stocks, including recent declines in sales and increased net losses. The company reported first-quarter sales of US$46.85 million, down from US$64.18 million a year prior, and a net loss of US$29.95 million compared to the previous year's US$12.08 million loss. Despite its unprofitability, Maravai has strong short-term liquidity with assets surpassing both short- and long-term liabilities and has reduced its debt-to-equity ratio over five years from 262.7% to 55.6%, indicating improved financial management amidst volatility concerns. Navigate through the intricacies of Maravai LifeSciences Holdings with our comprehensive balance sheet health report here. Assess Maravai LifeSciences Holdings' future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ranpak Holdings Corp. offers product protection and end-of-line automation solutions for e-commerce and industrial supply chains across North America, Europe, and Asia, with a market cap of approximately $306.61 million. Operations: The company generates $374.8 million in revenue from its product protection and automation solutions for e-commerce and industrial supply chains. Market Cap: $306.61M Ranpak Holdings, with a market cap of US$306.61 million, exemplifies the volatility and potential of penny stocks. Despite being unprofitable with increasing losses over five years and a negative return on equity, Ranpak maintains a seasoned management team and board. The company reported first-quarter revenue growth to US$91.2 million but also faced a net loss of US$10.9 million. Recent strategic partnerships, like the one with Thalia for automated packaging systems, highlight its commitment to innovation in e-commerce fulfillment solutions while managing high debt levels and maintaining sufficient cash runway for over three years. Click to explore a detailed breakdown of our findings in Ranpak Holdings' financial health report. Understand Ranpak Holdings' earnings outlook by examining our growth report. Explore the 709 names from our US Penny Stocks screener here. Ready To Venture Into Other Investment Styles? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ALDX MRVI and PACK. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
GST relief on new homes could save 1st-time buyers up to $240 on mortgages: report
OTTAWA — A new analysis says first-time Canadian homebuyers could save up to $240 on their monthly mortgage payments through the federal government's proposal to waive the sales tax on new builds. Desjardins Economics says in a new report that the impact on housing affordability will be "particularly strong" for buyers in Canada's more expensive markets, like Toronto and Vancouver. The Liberal government has tabled legislation to eliminate the GST portion from new home sales of up to $1 million for first-time buyers, which works out to as much as $50,000 off the cost of a new build or substantially renovated unit. For homes sold above $1 million, the GST relief is phased out as the price tag nears $1.5 million. But Desjardins also cautions that the policy could drive up demand for housing, which in the near-term could push up home prices if not coupled with other efforts to boost supply. Parliament has yet to pass the legislation, which the Liberals introduced alongside the government's pledge to cut income taxes starting July 1. This report by The Canadian Press was first published June 9, 2025. Craig Lord, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
36 minutes ago
- Yahoo
Mitsubishi plans battery swapping tech for electric CVs in Tokyo
Mitsubishi Fuso Truck and Bus (MFTBC), in collaboration with Mitsubishi Motors, Ample, and Yamato Transport, is set to roll out an EV battery swapping initiative in Tokyo, Japan, by September 2025. The plan includes introducing more than 150 battery-swappable commercial electric vehicles (EVs) and creating 14 modular battery swapping stations across the city. This major move towards sustainable transportation follows a smaller pilot in Kyoto last year and will feature MFTBC's eCanter light-duty truck and Mitsubishi Motors' Minicab EV, targeting commercial delivery fleets. Yamato Transport will be the first major customer, focusing on last-mile delivery applications. Ample, a US-based battery swapping company, will provide the technology for the EV platforms and will be responsible for installing and operating the swapping stations. The Tokyo Metropolitan Environment Public Corporation is backing the project through its "Technology Development Support Project for Promoting New Energy", aligning with Japan's climate goals. Japan aims to reduce greenhouse gas emissions by 46% from 2013 levels by 2030 and achieve carbon neutrality by 2050. With the transportation sector responsible for nearly 19% of the country's CO₂ emissions in 2022, commercial fleet electrification is a strategic priority for Japan's decarbonisation efforts. The consortium in Tokyo is targeting battery swapping times of just five minutes, offering a fully automated service where drivers do not need to exit their vehicles. Ample's compact and rapidly deployable stations are a practical solution for high-utilisation fleets in dense urban areas like Tokyo. Future expansions of this initiative may include grid services, such as renewable energy storage, to further reduce greenhouse gas emissions. This initiative builds on previous collaborations, with Yamato Transport pioneering commercial EV battery swapping since 2022 and a successful pilot involving commercial delivery and battery swapping taxis in Kyoto in 2024. "Mitsubishi plans battery swapping tech for electric CVs in Tokyo" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
